Kendi, Ayse T
Mayo Clinic · Memorial Sloan Kettering Cancer Center · University of Arizona · Université Paris-Saclay · University Hospital Münster · Dana-Farber Cancer Institute · Weill Cornell Medicine · University of Rostock
5 papers on CoChatORCID 0000-0003-3892-4754
Most cited papers
- Verified
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
Fizazi, K., Herrmann, K., Krause, B. J., Rahbar, K., Chi, K. N., Morris, M. J., Sartor, O., Tagawa, S. T., Kendi, A. T., Vogelzang, N., et al. (2023) · The Lancet Oncology
Prostate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and Applications
Cited by 125
- Verified
Quantitative 68 Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177 Lu-PSMA-617 (VISION Trial)
Kuo, P. H., Morris, M. J., Hesterman, J., Kendi, A. T., Rahbar, K., Wei, X. X., Fang, B., Adra, N., Garje, R., Michalski, J. M., et al. (2024) · Radiology
Radiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and Research
Cited by 119
- Verified
[68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy.
Kuo, P., Hesterman, J., Rahbar, K., Kendi, A. T., Wei, X. X., Fang, B., Adra, N., Armstrong, A. J., Garje, R., Michalski, J. M., et al. (2022) · Journal of Clinical Oncology
Radiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and Applications
Cited by 83
- Verified
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going
Muniz, M., Loprinzi, C. L., Orme, J. J., Koch, R. M., Mahmoud, A. M., Kase, A. M., Riaz, I. B., Andrews, J. R., Thorpe, M. P., Johnson, G. B., et al. (2024) · Cancer Treatment Reviews
Radiopharmaceutical Chemistry and ApplicationsOral health in cancer treatment
Cited by 35
- Verified
A VISION Substudy of Reader Agreement on 68 Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177 Lu-PSMA-617 Radioligand Therapy
Kuo, P. H., Yoo, D. C., Avery, R., Seltzer, M., Calais, J., Nagarajah, J., Weber, W. A., Fendler, W. P., Hofman, M. S., Krause, B. J., et al. (2023) · Journal of Nuclear Medicine
Medical Imaging Techniques and ApplicationsRadiopharmaceutical Chemistry and Applications
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free